SPOTLIGHT: Calpers withholding votes from Lilly directors

California's public-employee pension fund will withhold its votes for three Eli Lilly directors up for re-election next month, citing a lagging stock price and poor corporate governance. Among the three is John Lechleiter (photo), scheduled to become chief executive next month. Report

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.